Back to search
Infiltrating Urothelial Carcinoma, Sarcomatoid Variant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infiltrating Urothelial Carcinoma, Sarcomatoid Variant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Infiltrating Urothelial Carcinoma, Sarcomatoid Variant trials you may qualify forThis phase I trial studies the side effects and best dose of belinostat when given together with durvalumab in treating patients with urothelial cancer that has…
This pilot phase I trial studies the side effects of durvalumab and tremelimumab in treating patients with muscle-invasive, high-risk urothelial cancer that can…
This phase II trial studies how well pemetrexed and avelumab work in treating patients with MTAP-deficient urothelial cancer that has spread to other places in…
This phase II trial studies the side effects of durvalumab and chemotherapy before surgery in treating patients with variant histology bladder cancer. Immunothe…